Methodological survey of designed uneven randomization trials (DU-RANDOM): A protocol

Trials

Volumn 15, Issue 1, 2014, Pages

  Wu, Darong ^a,c   Akl, Elie A ^b,c,d   Guyatt, Gordon H ^c   Devereaux, Philip J ^c   Brignardello Petersen, Romina ^e,f   Prediger, Barbara ^g   Patel, Krupesh ^c   Patel, Namrata ^d   Lu, Taoying ^a   Zhang, Yuan ^c   Falavigna, Maicon ^c,h   Santesso, Nancy ^c   Mustafa, Reem A ⁱ   Zhou, Qi ^c   Briel, Matthias ^j   Schünemann, Holger J ^c  

^a GUANGDONG PROVINCIAL HOSPITAL OF CHINESE MEDICINE   (China)

^b AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^c MCMASTER UNIVERSITY   (Canada)

^d UNIVERSITY AT BUFFALO   (United States)

^e UNIVERSITY OF TORONTO   (Canada)

^f UNIVERSITY OF CHILE   (Chile)

^g UNIVERSITY OF FREIBURG   (Germany)

^h FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

ⁱ UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

^j UNIVERSITY HOSPITAL BASEL   (Switzerland)

more..

Author keywords

Designed uneven randomization trials; Participation rate; Trial participation

Indexed keywords

ARTICLE; DATA ANALYSIS; DATA EXTRACTION; DESCRIPTIVE RESEARCH; HUMAN; INFORMED CONSENT; MEDICAL LITERATURE; PUBLICATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); SAMPLE SIZE; STUDY DESIGN; SYSTEMATIC REVIEW;

HUMANS; INFORMED CONSENT; JOURNAL IMPACT FACTOR; LINEAR MODELS; PATIENT SELECTION; PERIODICALS AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN; SAMPLE SIZE;

EID: 84892702435     PISSN: None     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/1745-6215-15-33     Document Type: Article

References (37)

1. Easterbrook PJ, Matthews DR. Fate of research studies. J R Soc Med 1992, 85(2):71-76. 1294885, 1538384.
2. Ashery RS, McAuliffe WE. Implementation issues and techniques in randomized trials of outpatient psychosocial treatments for drug abusers: recruitment of subjects. Am J Drug Alcohol Abuse 1992, 18(3):305-329. 10.3109/00952999209026069, 1329493.
3. Charlson ME, Horwitz RI. Applying results of randomised trials to clinical practice: impact of losses before randomisation. Br Med J (Clin Res Ed) 1984, 289(6454):1281-1284. 10.1136/bmj.289.6454.1281, 1443545, 6437520.
4. Foy R, Parry J, Duggan A, Delaney B, Wilson S, Lewin-Van Den Broek NT, Lassen A, Vickers L, Myres P. How evidence based are recruitment strategies to randomized controlled trials in primary care? Experience from seven studies. Fam Pract 2003, 20(1):83-92. 10.1093/fampra/20.1.83, 12509377.
5. Haidich AB, Ioannidis JP. Patterns of patient enrollment in randomized controlled trials. J Clin Epidemiol 2001, 54(9):877-883. 10.1016/S0895-4356(01)00353-5, 11520646.
6. McDonald AM, Knight RC, Campbell MK, Entwistle VA, Grant AM, Cook JA, Elbourne DR, Francis D, Garcia J, Roberts I, et al. What influences recruitment to randomised controlled trials? A review of trials funded by two UK funding agencies. Trials 2006, 7:9. 10.1186/1745-6215-7-9, 1475627, 16603070.
7. Prescott RJ, Counsell CE, Gillespie WJ, Grant AM, Russell IT, Kiauka S, Colthart IR, Ross S, Shepherd SM, Russell D. Factors that limit the quality, number and progress of randomised controlled trials. Health Technol Assess 1999, 3(20):1-143.
8. Yeomans-Kinney A, Vernon SW, Frankowski RF, Weber DM, Bitsura JM, Vogel VG. Factors related to enrollment in the breast cancer prevention trial at a comprehensive cancer center during the first year of recruitment. Cancer 1995, 76(1):46-56. 10.1002/1097-0142(19950701)76:1<46::AID-CNCR2820760107>3.0.CO;2-B, 8630876.
9. Bergmann JF, Chassany O, Gandiol J, Deblois P, Kanis JA, Segrestaa JM, Caulin C, Dahan R. A randomised clinical trial of the effect of informed consent on the analgesic activity of placebo and naproxen in cancer pain. Clin Trials Metaanal 1994, 29(1):41-47.
10. Myles PS, Fletcher HE, Cairo S, Madder H, McRae R, Cooper J, Devonshire D, Hunt JO, Richardson J, Machlin H, et al. Randomized trial of informed consent and recruitment for clinical trials in the immediate preoperative period. Anesthesiology 1999, 91(4):969-978. 10.1097/00000542-199910000-00016, 10519499.
11. Cassileth BR, Zupkis RV, Sutton-Smith K, March V. Informed consent - why are its goals imperfectly realized?. N Engl J Med 1980, 302(16):896-900. 10.1056/NEJM198004173021605, 7360175.
12. Gallo C, Perrone F, De Placido S, Giusti C. Informed versus randomised consent to clinical trials. Lancet 1995, 346(8982):1060-1064. 10.1016/S0140-6736(95)91741-1, 7564786.
13. Turkington D, Kingdon D, Turner T. Effectiveness of a brief cognitive-behavioural therapy intervention in the treatment of schizophrenia. Br J Psychiatry 2002, 180:523-527. 10.1192/bjp.180.6.523, 12042231.
14. Dumville JC, Hahn S, Miles JN, Torgerson DJ. The use of unequal randomisation ratios in clinical trials: a review. Contemp Clin Trials 2006, 27(1):1-12.
15. Avins AL. Can unequal be more fair? Ethics, subject allocation, and randomised clinical trials. J Med Ethics 1998, 24(6):401-408. 10.1136/jme.24.6.401, 479141, 9873981.
16. Gail MWR, Byar DP, Brown C. How many controls. J Chronic Dis 1976, 29(11):723-731. 10.1016/0021-9681(76)90073-4, 791962.
17. Singer J. Estimating sample size for continuous outcomes, comparing more than two parallel groups with unequal sizes. Stat Med 1997, 16(24):2805-2811. 10.1002/(SICI)1097-0258(19971230)16:24<2805::AID-SIM676>3.0.CO;2-B, 9483715.
18. Treweek S, Mitchell E, Pitkethly M, Cook J, Kjeldstrom M, Taskila T, Johansen M, Sullivan F, Wilson S, Jackson C, et al. Strategies to improve recruitment to randomised controlled trials. Cochrane Database Syst Rev 2010, 1. MR000013.
19. Perrone F, De Placido S, Giusti C, Gallo C. The request for consent in clinical research: a randomized study in healthy subjects. Epidemiol Prev 1995, 19(64):282-290.
20. Ludwig J, Sanbonmatsu L, Gennetian L, Adam E, Duncan GJ, Katz LF, Kessler RC, Kling JR, Lindau ST, Whitaker RC, et al. Neighborhoods, obesity, and diabetes - a randomized social experiment. N Engl J Med 2011, 365(16):1509-1519. 10.1056/NEJMsa1103216, 3410541, 22010917.
21. Kromhout D, Giltay EJ, Geleijnse JM. n-3 fatty acids and cardiovascular events after myocardial infarction. N Engl J Med 2010, 363(21):2015-2026. 10.1056/NEJMoa1003603, 20929341.
22. Allen KD, Oddone EZ, Coffman CJ, Datta SK, Juntilla KA, Lindquist JH, Walker TA, Weinberger M, Bosworth HB. Telephone-based self-management of osteoarthritis: a randomized trial. Ann Intern Med 2010, 153(9):570-579. 10.7326/0003-4819-153-9-201011020-00006, 21041576.
23. Bennell K, Wee E, Coburn S, Green S, Harris A, Staples M, Forbes A, Buchbinder R. Efficacy of standardised manual therapy and home exercise programme for chronic rotator cuff disease: randomised placebo controlled trial. BMJ 2010, 340:c2756. 10.1136/bmj.c2756, 2882554, 20530557.
24. Jorde R, Sneve M, Torjesen P, Figenschau Y. No improvement in cardiovascular risk factors in overweight and obese subjects after supplementation with vitamin D3 for 1 year. J Intern Med 2010, 267(5):462-472. 10.1111/j.1365-2796.2009.02181.x, 20141565.
25. Bosworth HB, Olsen MK, Grubber JM, Powers BJ, Oddone EZ. Racial differences in two self-management hypertension interventions. Am J Med 2011, 124(5):e461-e468. 468.
26. Duncan PW, Sullivan KJ, Behrman AL, Azen SP, Wu SS, Nadeau SE, Dobkin BH, Rose DK, Tilson JK, Cen S, et al. Body-weight-supported treadmill rehabilitation after stroke. N Engl J Med 2011, 364(21):2026-2036. 10.1056/NEJMoa1010790, 3175688, 21612471.
27. Akl EA, Briel M, You JJ, Sun X, Johnston BC, Busse JW, Mulla S, Lamontagne F, Bassler D, Vera C, et al. Potential impact on estimated treatment effects of information lost to follow-up in randomised controlled trials (LOST-IT): systematic review. BMJ 2012, 344:e2809. 10.1136/bmj.e2809, 22611167.
28. Akl EA, Sun X, Busse JW, Johnston BC, Briel M, Mulla S, You JJ, Bassler D, Lamontagne F, Vera C, et al. Specific instructions for estimating unclearly reported blinding status in randomized trials were reliable and valid. J Clin Epidemiol 2012, 65(3):262-267. 10.1016/j.jclinepi.2011.04.015, 22200346.
29. Lee KP, Schotland M, Bacchetti P, Bero LA. Association of journal quality indicators with methodological quality of clinical research articles. JAMA 2002, 287(21):2805-2808. 10.1001/jama.287.21.2805, 12038918.
30. Torgerson D, Campbell M. Unequal randomisation can improve the economic efficiency of clinical trials. J Health Serv Res Policy 1997, 2(2):81-85.
31. Gottlieb MS, Zackin RA, Fiala M, Henry DH, Marcel AJ, Combs KL, Vieira J, Liebman HA, Cone LA, Hillman KS, et al. Response to treatment with the leukocyte-derived immunomodulator IMREG-1 in immunocompromised patients with AIDS-related complex. A multicenter, double-blind, placebo-controlled trial. Ann Intern Med 1991, 115(2):84-91. 10.7326/0003-4819-115-2-84, 1676251.
32. Chow SC, Chang M. Adaptive design methods in clinical trials - a review. Orphanet J Rare Dis 2008, 3:11. 10.1186/1750-1172-3-11, 2422839, 18454853.
33. Mace AE. Sample-Size Determination 1974, 81-82. Huntington, NY: Robert Krieger.
34. Lachin JM. Statistical properties of randomization in clinical trials. Control Clin Trials 1988, 9(4):289-311. 10.1016/0197-2456(88)90045-1, 3060315.
35. McEntegart D, Dawson R. Re Dumville et al. Contemp Clin Trials 2006, 27:1-12. Contemp Clin Trials 2006, 27(2):207; author reply 207-208, 10.1016/j.cct.2005.08.003, 16236557.
36. Schulz KF, Altman DG, Moher D. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ 2010, 340:c332. 10.1136/bmj.c332, 2844940, 20332509.
37. Hunninghake DB, Darby CA, Probstfield JL. Recruitment experience in clinical trials: literature summary and annotated bibliography. Control Clin Trials 1987, 8(4 Suppl):6S-30S.